PACS
PACS Group, Inc. NYSE$32.52
Mkt Cap $5.1B
52w Low $7.50
70.3% of range
52w High $43.08
50d MA $34.79
200d MA $25.04
P/E (TTM)
26.8x
EV/EBITDA
24.6x
P/B
5.4x
Debt/Equity
3.4x
ROE
20.2%
P/FCF
20.1x
RSI (14)
—
ATR (14)
—
Beta
0.06
50d MA
$34.79
200d MA
$25.04
Avg Volume
887.3K
About
PACS Group, Inc. is a holding company, which engages in the provision of post-acute healthcare facilities, professionals, and ancillary services. It provides senior care, assisted living, and independent living options in some of the communities. The company was founded by Jason Murray and Mark Hancock in 2013 and is headquartered in Farmington, UT.
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | AMC | 0.48 | 0.43 | -10.4% | 41.67 | -7.8% | -12.4% | -9.3% | -11.5% | -12.8% | -14.6% | — |
| Nov 19, 2025 | AMC | 0.45 | 0.32 | -28.9% | 16.83 | +52.6% | +55.3% | +63.4% | +78.0% | +88.8% | +91.1% | — |
| Aug 12, 2024 | AMC | 0.35 | -0.07 | -120.7% | 32.35 | +12.8% | +18.8% | +18.1% | +23.4% | +19.9% | +23.1% | — |
| May 13, 2024 | AMC | 0.29 | 0.33 | +13.7% | 25.08 | +2.8% | +7.3% | +13.0% | +12.8% | +12.5% | +13.8% | — |
| Sep 30, 2023 | AMC | — | 0.13 | — | — | — | — | — | — | — | — | — |
| Jun 30, 2023 | AMC | — | 0.14 | — | — | — | — | — | — | — | — | — |
| Mar 31, 2023 | AMC | — | 0.25 | — | — | — | — | — | — | — | — | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 4 | UBS | Maintains | Buy → Buy | — | $36.87 | $37.39 | +1.4% | -1.4% | -3.5% | -7.0% | -7.5% | -7.3% |
| Mar 4 | Oppenheimer | Maintains | Outperform → Outperform | — | $36.87 | $37.39 | +1.4% | -1.4% | -3.5% | -7.0% | -7.5% | -7.3% |
| Feb 27 | RBC Capital | Maintains | Outperform → Outperform | — | $41.67 | $38.40 | -7.8% | -12.4% | -9.3% | -11.5% | -12.8% | -14.6% |
| Nov 20 | RBC Capital | Maintains | Outperform → Outperform | — | $16.83 | $25.69 | +52.6% | +55.3% | +63.4% | +78.0% | +88.8% | +91.1% |
| Jan 6 | Macquarie | Maintains | Outperform → Outperform | — | $13.35 | $13.39 | +0.3% | +0.1% | -0.7% | -1.1% | -3.9% | -0.1% |
| Jan 6 | Truist | Maintains | Buy → Buy | — | $13.35 | $13.39 | +0.3% | +0.1% | -0.7% | -1.1% | -3.9% | -0.1% |
| Dec 17 | JP Morgan | Downgrade | Overweight → Neutral | — | $15.18 | $14.70 | -3.2% | -8.1% | -13.8% | -13.9% | -14.3% | -13.8% |
| Nov 18 | Stephens & Co. | Maintains | Overweight → Overweight | — | $17.41 | $17.27 | -0.8% | -2.8% | -1.8% | -0.9% | -4.9% | -5.2% |
| Oct 14 | Truist | Maintains | Buy → Buy | — | $39.14 | $39.41 | +0.7% | +2.5% | +4.6% | +7.1% | +5.6% | +7.0% |
| Aug 15 | Truist | Maintains | Buy → Buy | — | $38.21 | $39.15 | +2.5% | +4.5% | +1.5% | +4.2% | +2.1% | +4.8% |
Recent Filings
8-K · 5.02
!!! Very High
PACS Group, Inc. -- 8-K 5.02: Executive Change
Carey Hendrickson's appointment as CFO of PACS Group signals management strengthening and potential strategic shifts in financial oversight and capital allocation decisions.
Apr 27
8-K · 5.02
!!! Very High
PACS Group, Inc. -- 8-K 5.02: Executive Change
Patrick H. Conway's appointment as Class III director at PACS Group adds new board representation, potentially bringing fresh strategic oversight to the company's operations.
Mar 5
8-K
PACS Group, Inc. -- 8-K Filing
PACS Group announced 2025 full-year and Q4 results with a conference call scheduled for February 26, 2026, allowing investors to hear management's performance commentary and guidance directly.
Feb 26
Data updated apr 26, 2026 6:28pm
· Source: massive.com